Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...

Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Mt. Olive, NJ, June 18, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective June 17, 2024, Donald Gilliam was granted a...

Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Mt. Olive, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective January 1, 2024, Bill Sweeney was granted a...

Xebec annonce l’octroi d’unités d’actions restreintes MONTRÉAL, 25 nov. 2020 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSXV : XBC) (« Xebec »), fournisseur mondial de solutions d’énergie propre, est ravi d’annoncer aujourd’hui l’octroi d’unités...

Xebec Announces Grant of Restricted Stock Units MONTREAL, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), a global provider of clean energy solutions, announced today that it has granted restricted stock units...